Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-24 @ 11:24 PM
NCT ID:
NCT04804956
Eligibility Criteria:
Inclusion Criteria:
* Patients with rectal cancer that will undergo anterior resection for rectal cancer.
* Age ≥ 18 years
* Histology proven adenocarcinoma or adenoma with or without chemotherapy or neoadjuvant radiochemotherapy
* Tumoral stage equal or grater than T1
* Attempt to R0 resection
* Signed informed consent by the patient and by the researcher
* Dietary Questionnaire completed
Exclusion Criteria:
* Colorectal tumor with different histology to adenocarcinoma or adenoma
* History of colorectal cancer surgery different to the local excision
* Patients with psychiatric illness, addiction or disorder with inability to understand informed consent
* Inability to read or understand any of the languages of the informed consent and questionnaires (Catalan, spanish)
* Another synchronous malignancy
* Emergency Surgery
* Any patient that medical characteristics present an individual risk raised to be included and complete the study
* Severe kidney or liver disease
* Systemic disease with inflammatory activity, such as rheumatoid arthritis, Crohn's disease, asthma, chronic infection (HIV,TBC).
* Pregnancy and lactation
* Severe disorder of eating behaviour
* Clinical symptoms and sings of infection in the previous month
* Antibiotic, antifungal and antiviral treatment for the last 3 months
* Anti-inflammatory chronic treatment
* Major psychiatric antecedents
* Excessive alcohol intake or drug abuse
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
18 Years
Study:
NCT04804956
Study Brief:
Protocol Section:
NCT04804956